Molecular mediators of arterial inflammation: A role for microbial products?

This publication has 10 references indexed in Scilit:

• A Chlamydia pneumoniae Component That Induces Macrophage Foam Cell Formation Is Chlamydial Lipopolysaccharide
  Infection and Immunity, 1998
• Assessing the benefits of lipid-lowering therapy
  The American Journal of Cardiology, 1998
• Confirmed Previous Infection With Chlamydia pneumoniae (TWAR) and Its Presence in Early Coronary Atherosclerosis
  Circulation, 1998
• Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression
  Circulation, 1998
• The Mechanisms by Which Infectious Agents May Contribute to Atherosclerosis and Its Clinical Manifestations
  Trends in Cardiovascular Medicine, 1998
• Antibiotic Treatment of Chlamydia pneumoniae for Secondary Prevention of Cardiovascular Events
  Circulation, 1998
• Roles of Infectious Agents in Atherosclerosis and Restenosis
  Circulation, 1997
• ChronicChlamydia pneumoniaeInfection Is Associated With a Serum Lipid Profile Known to Be a Risk Factor for Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Molecular Bases of the Acute Coronary Syndromes
  Circulation, 1995
• Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.
  Microbiological Reviews, 1994